Edition:
United Kingdom

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

483.50DKK
15 Dec 2017
Change (% chg)

kr.-6.50 (-1.33%)
Prev Close
kr.490.00
Open
kr.489.50
Day's High
kr.489.60
Day's Low
kr.482.90
Volume
442,319
Avg. Vol
375,914
52-wk High
kr.594.00
52-wk Low
kr.457.50

Latest Key Developments (Source: Significant Developments)

Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Coloplast ::CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​.  Full Article

Coloplast sees 2017/2018 revenue growth at lower end of long-term outlook
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - COLOPLAST :Q4 REVENUE DKK 3.98‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q4 PRETAX PROFIT DKK ‍​1.33 BILLION (REUTERS POLL DKK 1.34 BILLION).‍EXPECT ORGANIC REVENUE GROWTH OF C7% AT CONSTANT EXCHANGE RATES.Q4 EBIT DKK ‍​1.32 BILLION (REUTERS POLL DKK 1.32 BILLION).‍EXPECTS IN 2017/2018 AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES​.‍IN 2017/2018 CAPITAL EXPENDITURE IS EXPECTED TO BE ABOUT DKK 700M AND EFFECTIVE TAX RATE IS EXPECTED TO BE ABOUT 23%​.‍RECOMMENDS TO APPROVE A YEAR-END DIVIDEND OF DKK 10.5 PER SHARE.​.‍INTENDS TO PURSUE INORGANIC GROWTH OPPORTUNITIES TO FURTHER STRENGTHEN ITS SERVICE OFFERING TO CONSUMER​.COLOPLAST - LONG-TERM ‍ORGANIC REVENUE GROWTH GUIDANCE IS MAINTAINED AT 7-9% P.A. WHERE AMBITION IS TO REACH UPPER END OF INTERVAL​.COLOPLAST - LONG-TERM, ‍EBIT MARGIN GUIDANCE REVISED FROM 50-100BP IMPROVEMENT P.A., TO EBIT MARGIN OF >30% AT CONSTANT CURRENCIES​.  Full Article

Coloplast CEO sells 117,260 shares in the company
Tuesday, 13 Dec 2016 

Coloplast : CEO sells 117,260 shares at 454.85 Danish crowns per share .Ado Holding Af 26.2.2004 aps, related party to CEO Lars Rasmussen, purchased shares worth 53,335,711.00 Danish crowns ($7.6 million).  Full Article

Coloplast Q3 EBIT DKK 1.20 billion, below estimates
Tuesday, 16 Aug 2016 

Coloplast : Q3 revenue 3.69 billion Danish crowns ($559.15 million) versus 3.72 billion crowns seen in Reuters poll . Q3 EBIT 1.20 billion crowns (Reuters poll 1.22 billion crowns) . Continues to expect organic revenue growth for 2015/16 of 7-8 pct at constant exchange rates and now of about 6 pct in Danish crowns from previously 6-7 pct . Continues to expect EBIT margin to be 33-34 pct at constant exchange rates and to be about 33 pct in Danish crowns for 2015/16 .2015/16 capital expenditure is still expected to be 600-700 million crowns; effective tax rate is still expected to be about 23 pct.  Full Article

Coloplast adjusts downwards 3-yr organic revenue growth outlook
Wednesday, 22 Jun 2016 

Coloplast A/S : Says Board approved new long-term financial guidance, spanning three years . Says new target for three years is organic revenue growth of 7-9 pct p.a. . Previous long-term guidance was organic revenue growth of 7-10 pct p.a. . Long-term financial guidance on EBIT-margin remains unchanged - EBIT-margin expansion of 1/2 - 1 percentage points p.a. . Says change in long-term organic revenue growth guidance is explained by challenging macroeconomic environment in emerging markets .Says financial guidance for 2015/16 is unchanged.  Full Article

Coloplast comments on FY 2015/16 outlook
Tuesday, 2 Feb 2016 

Coloplast A/S:Expects revenue growth of 7-8 pct at constant exchange rates and of around 7 pct in Danish crowns in FY 2015/16.Sees an EBIT margin of 33-34 pct at constant exchange rates and of around 33 pct in Danish crowns in FY 2015/16.  Full Article

BRIEF-Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​

* CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)